Mar 5, 2024
Familial Hypocalciuric Hypercalcemia (FHH)
Diagnostic Approach
Conclusion
Conclusion
An essential mineral, calcium is involved in many physiological functions, such as blood coagulation, hormone release, heart contractility, and neuromuscular communication. For cells to operate normally, extracellular calcium concentrations must be kept in a delicate balance and within the limited physiological range of 9–11 mg%.
This equilibrium is maintained by the complex interactions between parathyroid hormone (PTH), the active vitamin D metabolite calcitriol, and feedback processes involving the kidneys, intestines, bones, and parathyroid glands. The intricacies of hypercalcemia and hypocalcemia are examined in this blog, along with their causes, clinical signs, methods of diagnosis, and available treatments.
Hypercalcemia refers to elevated levels of calcium in the blood, disrupting the normal feedback mechanisms that regulate serum calcium. There are various etiologies for hypercalcemia, including excessive PTH production, malignancy-related hypercalcemia, and vitamin D intoxication.
The hallmark of FHH, an autosomal dominant disorder, is decreased extracellular calcium sensing as a result of gene abnormalities that impact calcium-sensing receptors.
Also Read: High yield NEET SS Medicine Endocrinology Questions
Hypercalcemic patients may exhibit systemic symptoms such as pain in the right upper quadrant, jaundice, weight loss, and abdominal mass. It is possible to experience neuropsychiatric symptoms such altered personality and trouble concentrating. The degree of hypercalcemia is correlated with the severity of symptoms.
PTH levels, albumin concentration, and serum calcium levels are measured as part of the diagnostic examination of hypercalcemia. Finding the root cause can be aided by imaging studies like CECT scans and ultrasonography. The eighth AJCC TNM classification aids in the staging of gallbladder cancer.
Also Read: Beta Blocker Gel Shows Potential for Treating Diabetic Foot Ulcers
The course of treatment differs according on the severity of hypercalcemia. While considerable symptomatic hypercalcemia necessitates therapeutic therapy, mild asymptomatic instances may not require immediate care. Treatment possibilities include volume expansion, calcitonin, bisphosphonates, and, in cases where response is refractory, gallium nitrate. Palliation is the primary treatment for gallbladder cancer stage IVb.
When treating high-risk lesions including R1 resection, positive lymph node involvement, and T4 tumors, adjuvant therapy—which includes gemcitabine and cisplatin—is taken into consideration.
Survival in carcinoma of the gallbladder depends on factors such as tumor stage, node involvement, histological differentiation, CBD involvement, and resection margins. The 5-year survival rates vary from 60% for T2 lesions to less than 20% for T3 lesions and are even lower for T4 lesions.
Hypercalcemia and carcinoma of the gallbladder are complex medical conditions that require a thorough understanding of their causes, clinical manifestations, and treatment options. A multidisciplinary approach involving medical, surgical, and palliative interventions is crucial for managing these conditions effectively. Regular monitoring and early intervention play key roles in improving patient outcomes.
The unusually low blood levels of calcium known as hypocalcemia provide serious obstacles to the regular operation of several physiological functions. The complexities of hypocalcemia are examined in this blog, which also provides information on its causes, clinical signs, methods of diagnosis, and available treatments.
Hypocalcemia can be broadly categorized into two types based on parathyroid hormone (PTH) levels:
Also Read: Navigating the Maze of Hereditary Pheochromocytoma and Paragangliomas Syndrome
The symptoms of hypocalcemia can vary in severity. Asymptomatic cases may go unnoticed, while moderate to severe hypocalcemia can present with:
Also Read: Acromegaly- Clinical Features, Diagnosis, Treatment
To accurately diagnose hypocalcemia, a thorough evaluation that takes into account serum calcium, albumin, phosphorus, and magnesium levels is necessary. The distinction between secondary hyperparathyroidism and hypoparathyroidism must be made based on PTH values.
Also Read: Metabolic Syndrome: A Comprehensive Guide to Understanding, Managing, and Thriving
Treatment for hypocalcemia is based on the degree, speed of onset, and coexisting problems. Intravenous calcium gluconate is the first line of treatment for acute, symptomatic hypocalcemia. If the hypocalcemia persists, intravenous infusion is then used. Vitamin D and calcium supplements are necessary for chronic hypocalcemia brought on by hypoparathyroidism. PTH (1-84) has emerged as a potentially effective treatment for hypoparathyroidism that is refractory.
Due to the complex nature of hypocalcemia and its range of etiologies, diagnosis and treatment must be approached with caution. In order to properly manage hypocalcemia, coordination between healthcare experts from different specializations is essential. Restoring calcium levels to the low-normal range is the aim of treatment in order to prevent problems brought on by both hypercalcemia and hypocalcemia. Patients with hypocalcemia benefit from individualized therapy, patient education, and routine monitoring.
Also Read: Special Considerations in Diabetes Mellitus
Hope you found this blog helpful for your NEET SS Endocrinology Preparation. For more informative and interesting posts like these, keep reading PrepLadder’s blogs.
Get access to all the essential resources required to ace your medical exam Preparation. Stay updated with the latest news and developments in the medical exam, improve your Medical Exam preparation, and turn your dreams into a reality!
The most popular search terms used by aspirants
Avail 24-Hr Free Trial